Browse All

Current Filters

CLEAR FILTER x

TITLE

Immune Reconstitution-related HIV Vacuolar Myelopathy in a 66-year-old Man

Safety and Tolerability of a Modified Ublituximab Dosing Regimen: Updates From the ENHANCE Study

Author:Singer, Barry   Herrman, Craig   Robertson, Derrick   Berrios Morales, Idanis   Dasari, Sidarth   Calkwood, Jonathan   Hughes, Mary   Scagnelli, John   Carlson, Alise   Brown, Theodore   Goldstick, Lawrence   Pardo, Gabriel   Wray, Sibyl   Sy, Michael   Belkin, Martin   Obeidat, Ahmed   Riser, Emily   Qian, Peiqing   Napoli, Salvatore   LaGanke, Christopher   Sportelli, Peter   Miskin, Hari   Fox, Edward   Rowland, Chris   Foley, John   

Session Name:P9: Multiple Sclerosis: Clinical Trials 2  

Topic:Multiple Sclerosis  

Program Number:P9.002  

Author Institution:MS Center for Innovations in Care, St. Louis, MO  JWM Neurology, Zionsville, IN  University of South Florida, Tampa, FL  University of Massachusetts Medical School, Worcester, MA  Advanced Neurology of Colorado, Fort Collins, CO  Minnesota Center for MS, Plymouth, MN  Premier Neurology, PC, Greenville, SC  Raleigh Neurology Associates, Raleigh, NC  Cleveland Clinic Mellen Center, Cleveland, OH  EvergreenHealth, Kirkland, WA  University of Cincinnati UC Physcians Department of Neurology, Dayton, OH  Oklahoma Medical Research Foundation, Oklahoma City, OK  Hope Neurology, Knoxville, TN  University of California, Irvine, Irvine, CA  Michigan Institute for Neurological Disorders, Farmington Hills, MI  Medical College of Wisconsin, Milwaukee, WI  Alabama Neurology Associates, Birmingham, AL  Swedish Medical Center, Mercer Island, WA  Neurology Center of New England, Foxboro, MA  North Central Neurology Associates, PC, Cullman, AL  TG Therapeutics, Stuart, FL  TG Therapeutics, New York, NY  TG Therapeutics, Round Rock, TX  TG Therapeutics, NC  Rocky Mountain MS Clinic, Salt Lake City, UT